# Hyacinth Bean (Lablab purpureus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/hyacinth-bean
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-20
**Evidence Score:** 2 / 10
**Category:** Ayurveda
**Also Known As:** Lablab purpureus, Dolichos bean, Dolichos lablab, Indian bean, Egyptian kidney bean, Bonavist bean, Sem, Val

## Overview

Hyacinth Bean (Lablab purpureus) contains bioactive lectins, flavonoids, and canavanine that contribute to its anticoagulant, antidiabetic, and [anti-inflammatory](/ingredients/condition/inflammation) properties. Its seed radicle extracts inhibit platelet aggregation and modulate [glucose metabolism](/ingredients/condition/weight-management) through enzyme inhibition pathways studied in preclinical models.

## Health Benefits

• Anticoagulant and anti-platelet effects demonstrated in preclinical studies using seed radicle extract at 1.5 mg/ml (evidence: preliminary/animal studies)
• Antidiabetic properties supported by traditional use and preclinical pharmacological screening (evidence: traditional use with preliminary validation)
• [Antioxidant activity](/ingredients/condition/antioxidant) from flavonoids and phenolic compounds in leaf and seed extracts (evidence: in-vitro studies only)
• Anti-obesity potential through metabolic disease protection mechanisms (evidence: preliminary, based on 2025 review PMID: 38961686)
• Antimicrobial and [immunomodulatory](/ingredients/condition/immune-support) effects shown in preclinical studies (evidence: in-vitro/animal models only)

## Mechanism of Action

Hyacinth Bean seed radicle extract exerts anticoagulant and anti-platelet effects at concentrations of approximately 1.5 mg/ml, likely through inhibition of thromboxane synthesis and interference with ADP-induced platelet aggregation pathways. Flavonoids and phenolic compounds present in the seeds inhibit alpha-glucosidase and alpha-amylase enzymes, slowing carbohydrate [digestion](/ingredients/condition/gut-health) and attenuating postprandial glucose spikes relevant to its antidiabetic activity. The lectin fraction may further modulate immune signaling via toll-like receptor pathways, contributing to observed [anti-inflammatory](/ingredients/condition/inflammation) effects.

## Clinical Summary

Evidence for Hyacinth Bean's health benefits currently rests primarily on preclinical in vitro and animal studies, with no large-scale randomized controlled human trials published to date. Anticoagulant effects were demonstrated in laboratory assays using seed radicle extract at 1.5 mg/ml, showing measurable inhibition of platelet aggregation. Antidiabetic properties have been corroborated through pharmacological enzyme-inhibition screening and traditional Ayurvedic documentation, but human pharmacokinetic and efficacy data remain absent. The overall evidence is preliminary, and clinical conclusions cannot yet be drawn without validated human trials.

## Nutritional Profile

Hyacinth Bean (Lablab purpureus) seeds are protein-rich legumes containing approximately 20–29% crude protein (dry weight basis), with a well-balanced amino acid profile including lysine (~6.4 g/100g protein), leucine, isoleucine, and valine, though methionine and cysteine are limiting amino acids typical of legumes. Carbohydrate content is approximately 55–65% (dry weight), with dietary fiber ranging from 5–10% including both soluble and insoluble fractions that support gut motility and glycemic modulation. Fat content is low at approximately 1–3%, predominantly unsaturated fatty acids including linoleic acid (omega-6). Key micronutrients include calcium (~130 mg/100g), phosphorus (~370 mg/100g), iron (~6–9 mg/100g), magnesium (~160 mg/100g), potassium (~1200 mg/100g), zinc (~3 mg/100g), and B-vitamins including thiamine (B1: ~0.5 mg/100g), riboflavin (B2: ~0.2 mg/100g), and niacin (B3: ~2 mg/100g). Bioactive compounds include flavonoids (kaempferol, quercetin glycosides), phenolic acids (gallic acid, caffeic acid), and tannins concentrated in seed coats and leaves. Seeds also contain lectins (phytohemagglutinins), cyanogenic glycosides, and trypsin inhibitors as antinutritional factors — these are significantly reduced by soaking (12–24 hours), boiling, or fermentation, improving bioavailability of protein (digestibility improves from ~60% raw to ~80–85% cooked) and minerals. Stachyose and raffinose oligosaccharides (~3–5%) are present and contribute to flatulence but are reduced by fermentation. Leaves contribute additional flavonoids and phenolics relevant to [antioxidant activity](/ingredients/condition/antioxidant) documented in extracts. Immature pods and seeds have a lower antinutrient burden and higher moisture content (~85–90% water).

## Dosage & Preparation

No clinically studied dosage ranges are available as human trials have not been conducted. Preclinical studies used seed radicle extract (LPRE) at 1.5 mg/ml for anticoagulant effects, but no standardized forms or safe dosage ranges have been established for human use. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Raw Hyacinth Bean seeds contain cyanogenic glycosides and lectins that are toxic if consumed uncooked, making thorough cooking or processing essential before use. Individuals taking anticoagulant or antiplatelet medications such as warfarin or clopidogrel should exercise caution due to additive blood-thinning effects suggested by preclinical data. Patients on antidiabetic drugs including metformin or insulin may face enhanced hypoglycemic risk if combining with Hyacinth Bean extracts, warranting medical supervision. Safety data during pregnancy and lactation are insufficient, and use is generally not recommended in these populations without professional guidance.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Hyacinth bean extracts. Current evidence is limited to preclinical pharmacological studies and a 2025 review (PMID: 38961686) summarizing health-promoting properties against metabolic diseases based on bioactive compound mechanisms rather than human trials.

## Historical & Cultural Context

In Indian traditional medicine, Lablab purpureus has been used as an antispasmodic, antidiabetic, febrifuge, and remedy for flatulence and phlegmatic disorders. Its cultivation and use as both a nutrient-rich food and medicinal plant dates back to ancient times in India and South-East Asia, where it remains an important pulse crop.

## Synergistic Combinations

Turmeric, Cinnamon, Fenugreek, Bitter Melon, Gymnema

## Frequently Asked Questions

### What is hyacinth bean used for in Ayurveda?

In Ayurvedic medicine, Hyacinth Bean (Lablab purpureus), known as 'Shimbi' or 'Val,' has traditionally been used to manage diabetes, digestive disorders, and inflammation. It is also applied topically in traditional formulations for skin conditions and is valued for its nutritive and rejuvenating properties within classical Ayurvedic texts.

### Is hyacinth bean safe to eat raw?

No, raw Hyacinth Bean seeds are unsafe for consumption because they contain cyanogenic glycosides and toxic lectins that can cause nausea, vomiting, and potentially severe poisoning. Thorough boiling or prolonged cooking effectively neutralizes these compounds, making the beans safe for dietary use.

### Does hyacinth bean lower blood sugar?

Preclinical pharmacological screening suggests that Hyacinth Bean extracts can inhibit alpha-glucosidase and alpha-amylase enzymes, which are key targets in managing postprandial blood glucose elevation. However, no human clinical trials have confirmed these antidiabetic effects, so it should not replace prescribed antidiabetic medications.

### What compounds in hyacinth bean have anticoagulant effects?

Seed radicle extracts of Lablab purpureus demonstrated anticoagulant and anti-platelet activity at a concentration of 1.5 mg/ml in preclinical studies, with lectins and phenolic compounds considered primary contributors. These constituents appear to interfere with thromboxane-mediated and ADP-induced platelet aggregation pathways based on in vitro assay data.

### Can hyacinth bean interact with blood thinners?

Yes, because Hyacinth Bean extracts exhibit anticoagulant and anti-platelet properties in preclinical models, combining them with pharmaceutical blood thinners such as warfarin, aspirin, or clopidogrel may potentiate bleeding risk. Anyone using anticoagulant therapy should consult a healthcare provider before adding Hyacinth Bean supplements to their regimen.

### What is the difference between hyacinth bean leaf extract and seed extract for antioxidant benefits?

Both hyacinth bean leaf and seed extracts contain flavonoids and phenolic compounds with antioxidant activity, but seed extracts have been more extensively studied for anticoagulant and antidiabetic properties. Leaf extracts may offer a lighter alternative with similar antioxidant potential but fewer systemic effects on blood clotting. The specific phytochemical profiles differ between plant parts, making seed extracts the more researched form for therapeutic applications.

### Who should avoid hyacinth bean supplements due to blood-thinning effects?

People taking prescription anticoagulants (such as warfarin or direct oral anticoagulants), antiplatelet medications (like aspirin or clopidogrel), or those with bleeding disorders should avoid hyacinth bean supplementation without medical supervision. Individuals scheduled for surgery within two weeks should also consult their healthcare provider, as the ingredient's antiplatelet effects may increase bleeding risk. Pregnant women should avoid it due to potential uterine stimulant properties in traditional use.

### What does current clinical research show about hyacinth bean's effectiveness compared to animal studies?

Most evidence for hyacinth bean's anticoagulant, antidiabetic, and antioxidant effects comes from preclinical and animal studies, with limited human clinical trials to date. The anticoagulant activity demonstrated in seed radicle extracts at 1.5 mg/ml in laboratory settings has not been directly translated to human dosing recommendations. While traditional Ayurvedic use supports antidiabetic properties, robust randomized controlled trials in humans are needed to establish safety and efficacy for supplemental use.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*